A new molecular classification of multiple myeloma using gene expression profiling and fluorescence in situ hybridisation as predictor for event free survival.

被引：3

作者：

Hose, D

Rossi, JF

Ittrich, C

DeVos, J

Benner, A

Reme, T

Bila, J

Grau, V

Raab, M

Kaukel, P

Jourdan, E

Moos, M

Theil, AC

Jauch, A

Goldschmidt, H

Klein, B

Cremer, FW

机构：

[1] Univ Klinikum Heidelberg, Inst Humangenet, Heidelberg, Germany

[2] DKFZ, Biostat Abt, Heidelberg, Germany

[3] INSERM, U475, Montpellier, France

[4] CHU Montpellier, Montpellier, France

[5] Cellgen SA, Montpellier, France

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.73.73

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：25A / 25A

页数：1

共 50 条

[31] Gene expression profiling predicts relapse-free and overall survival in newly diagnosed myeloma patients treated with novel therapies
Manasanch, Elisabet E.
Berrios, David
Fountain, Eric
Claussen, Catherine M.
Chuang, Tammy
Kaufman, Gregory
Amini, Behrang
Bashir, Qaiser
Nieto, Yago
Qazilbash, Muzaffar
Patel, Krina
Thomas, Sheeba K.
Weber, Donna M.
Berkova, Zuzana
Toruner, Gokce
Lin, Pei
Feng, Lei
Lee, Hans C.
Orlowski, Robert Z.
Kunacheewa, Chutima
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (04) : e115 - e120
[32] Predicting the Progression from Asymptomatic to Symptomatic Multiple Myeloma and Stage Classification Using Gene Expression Data
Karathanasis, Nestoras
Spyrou, George M.
CANCERS, 2025, 17 (02)
[33] SKY92 gene expression profiling and cytogenetics according to R2-ISS for multiple myeloma risk classification
Zhou, Xiang
Engel, Benedict
Hofmann, Annika
Vogt, Cornelia
Nerreter, Silvia
Teufel, Eva
Stanojkovska, Emilia
Truger, Marietta
Xiao, Xianghui
Riedhammer, Christine
Munawar, Umair
Han, Seungbin
Haertle, Larissa
Haferlach, Claudia
Einsele, Hermann
Rasche, Leo
Kortuem, Martin
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S271 - S271
[34] Multiple myeloma patients achieving molecular remission after transplantation of hematopoietic cells had a significantly lower relapse rate and higher relapse free survival.
Martinelli, G
Terragna, C
Cavo, M
Lemoli, RM
Bandini, G
Zamagni, E
Ronconi, S
Tosí, P
Motta, MR
Testoni, N
Amabile, M
Ottaviani, E
Vianelli, N
de Vivo, A
Tura, S
BLOOD, 1999, 94 (10) : 286A - 286A
[35] Risk classification of cancer survival using ANN with gene expression data from multiple laboratories
Chen, Yen-Chen
Ke, Wan-Chi
Chiu, Hung-Wen
COMPUTERS IN BIOLOGY AND MEDICINE, 2014, 48 : 1 - 7
[36] A2A or Beta-2 Adrenergic Receptor Agonist Synergies Induce Distinct Patterns of Gene Expression Relevant to Multiple Myeloma Cell Survival.
Tam, Winnie F.
Rickles, Richard J.
Giordano, Thomas
Borisy, Alexis
Lee, Margaret S.
BLOOD, 2009, 114 (22) : 1474 - 1474
[37] Gene expression profiling of multiple myeloma plasma cells allows identification of potential molecular determinants of lytic bone disease.
Zhan, FH
Randolph, C
Suva, L
Barlogie, B
Epstein, J
Shaughnessy, J
BLOOD, 2002, 100 (11) : 208A - 208A
[38] Gene Expression Profiling Of Multiple Myeloma Samples Using RNA Sequencing Identifies Frequent Rearrangements Of FCHSD2
Yellapantula, Venkata D.
Murray, Christopher
Liang, Winnie
Auclair, Daniel
Levy, Joan
Carpten, John
Keats, Jonathan J.
BLOOD, 2013, 122 (21)
[39] Microarray-Based Gene Expression Profiling for Molecular Classification of Breast Cancer and Identification of New Targets for Therapy
Sandhu, Rupninder
Parker, Joel S.
Jones, Wendell D.
Livasy, Chad A.
Coleman, William B.
LABMEDICINE, 2010, 41 (06): : 364 - 372
[40] Deletion of p53 as detected by fluorescence in situ hybridization is associated with significant shorter event-free survival in patients with multiple myeloma who are receiving allogeneic blood stem cell transplantation
Schilling, G
Hansen, T
Perez-Simon, JA
Schwerdtfeger, R
Bornhaeuser, M
Otterstetter, S
Seeger, D
Dierlamm, J
Ayuk, F
Kurt, HD
Carsten, B
Axel, ZR
Nicolaus, K
BLOOD, 2005, 106 (11) : 164B - 164B

← 1 2 3 4 5 →